Aurobindo Pharma Market Cap

Aurobindo Pharma has a market cap or net worth of 668.04 billion as of June 13, 2025. Its market cap has decreased by -4.70% in one year.

Market Cap

668.04B

Enterprise Value

668.25B

Revenue

317.24B

Ranking

n/a

PE Ratio

19.23

Stock Price

1,150.20

Market Cap Chart

Since July 1, 2002, Aurobindo Pharma's market cap has increased from 9.60B to 668.04B, an increase of 6,856.36%. That is a compound annual growth rate of 20.29%.

Market Cap History

Date	Market Cap	% Change
Jun 13, 2025	668.04B	-13.81%
Dec 31, 2024	775.08B	22.03%
Dec 29, 2023	635.16B	147.32%
Dec 30, 2022	256.82B	-40.31%
Dec 31, 2021	430.28B	-20.29%
Dec 31, 2020	539.83B	101.66%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Sun Pharmaceutical Industries	4,056.32B
Divi's Laboratories	1,783.68B
Cipla	1,213.80B
Apollo Hospitals Enterprise	1,005.99B
Mankind Pharma	986.42B
Zydus Lifesciences	984.90B
Alkem Laboratories	584.13B
Fortis Healthcare	573.77B

Market Cap Rankings